BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

111 related articles for article (PubMed ID: 35963423)

  • 1. DNA damage, DNA repair gene expression, and topoisomerase IIα activity in CD-1 mice following in utero benzene exposure.
    Holmes TH; Winn LM
    Toxicol Lett; 2022 Sep; 368():47-55. PubMed ID: 35963423
    [TBL] [Abstract][Full Text] [Related]  

  • 2. DNA Damage and Perturbed Topoisomerase IIα as a Target of 1,4-Benzoquinone Toxicity in Murine Fetal Liver Cells.
    Holmes TH; Winn LM
    Toxicol Sci; 2019 Oct; 171(2):339-346. PubMed ID: 31340051
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Decreased topoisomerase IIα expression and altered histone and regulatory factors of topoisomerase IIα promoter in patients with chronic benzene poisoning.
    Yu K; Shi YF; Yang KY; Zhuang Y; Zhu RH; Xu X; Cai G
    Toxicol Lett; 2011 Jun; 203(2):111-7. PubMed ID: 21382456
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The effects of 1,4-benzoquinone on c-Myb and topoisomerase II in K-562 cells.
    Singh R; Winn LM
    Mutat Res; 2008 Oct; 645(1-2):33-8. PubMed ID: 18778717
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Modulation of topoisomerase IIα expression and chemosensitivity through targeted inhibition of NF-Y:DNA binding by a diamino p-anisyl-benzimidazole (Hx) polyamide.
    Pett L; Kiakos K; Satam V; Patil P; Laughlin-Toth S; Gregory M; Bowerman M; Olson K; Savagian M; Lee M; Lee M; Wilson WD; Hochhauser D; Hartley JA
    Biochim Biophys Acta Gene Regul Mech; 2017 May; 1860(5):617-629. PubMed ID: 27750031
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Histone Deacetylase Inhibitors Trichostatin A and MCP30 Relieve Benzene-Induced Hematotoxicity via Restoring Topoisomerase IIα.
    Chen J; Zheng Z; Chen Y; Li J; Qian S; Shi Y; Sun L; Han Y; Zhang S; Yu K
    PLoS One; 2016; 11(4):e0153330. PubMed ID: 27058040
    [TBL] [Abstract][Full Text] [Related]  

  • 7. In utero and acute exposure to benzene: investigation of DNA double-strand breaks and DNA recombination in mice.
    Lau A; Belanger CL; Winn LM
    Mutat Res; 2009 May; 676(1-2):74-82. PubMed ID: 19486867
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Modulation of topoisomerase IIalpha expression by a DNA sequence-specific polyamide.
    Hochhauser D; Kotecha M; O'hare C; Morris PJ; Hartley JM; Taherbhai Z; Harris D; Forni C; Mantovani R; Lee M; Hartley JA
    Mol Cancer Ther; 2007 Jan; 6(1):346-54. PubMed ID: 17237293
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Roles of the C-terminal domains of topoisomerase IIα and topoisomerase IIβ in regulation of the decatenation checkpoint.
    Kozuki T; Chikamori K; Surleac MD; Micluta MA; Petrescu AJ; Norris EJ; Elson P; Hoeltge GA; Grabowski DR; Porter ACG; Ganapathi RN; Ganapathi MK
    Nucleic Acids Res; 2017 Jun; 45(10):5995-6010. PubMed ID: 28472494
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Investigating the effects of in utero benzene exposure on epigenetic modifications in maternal and fetal CD-1 mice.
    Philbrook NA; Winn LM
    Toxicol Appl Pharmacol; 2015 Nov; 289(1):12-9. PubMed ID: 26341289
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A cysteine-reactive alkyl hydroquinone modifies topoisomerase IIα, enhances DNA breakage, and induces apoptosis in cancer cells.
    Lin TY; Huang CP; Au LC; Chang YW; Hu CY; Lin SB
    Chem Res Toxicol; 2012 Nov; 25(11):2340-51. PubMed ID: 23088786
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Stimulation of topoisomerase II-mediated DNA cleavage by benzene metabolites.
    Lindsey RH; Bender RP; Osheroff N
    Chem Biol Interact; 2005 May; 153-154():197-205. PubMed ID: 15935817
    [TBL] [Abstract][Full Text] [Related]  

  • 13. XPO1 Inhibition using Selinexor Synergizes with Chemotherapy in Acute Myeloid Leukemia by Targeting DNA Repair and Restoring Topoisomerase IIα to the Nucleus.
    Ranganathan P; Kashyap T; Yu X; Meng X; Lai TH; McNeil B; Bhatnagar B; Shacham S; Kauffman M; Dorrance AM; Blum W; Sampath D; Landesman Y; Garzon R
    Clin Cancer Res; 2016 Dec; 22(24):6142-6152. PubMed ID: 27358488
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Inhibition of topoisomerase IIα and induction of DNA damage in cholangiocarcinoma cells by altholactone and its halogenated benzoate derivatives.
    Kitdumrongthum S; Reabroi S; Suksen K; Tuchinda P; Munyoo B; Mahalapbutr P; Rungrotmongkol T; Ounjai P; Chairoungdua A
    Biomed Pharmacother; 2020 Jul; 127():110149. PubMed ID: 32344256
    [TBL] [Abstract][Full Text] [Related]  

  • 15. β-Elemene Inhibits Cell Proliferation by Regulating the Expression and Activity of Topoisomerases I and IIα in Human Hepatocarcinoma HepG-2 Cells.
    Gong M; Liu Y; Zhang J; Gao YJ; Zhai PP; Su X; Li X; Li Y; Hou L; Cui XN
    Biomed Res Int; 2015; 2015():153987. PubMed ID: 26221582
    [TBL] [Abstract][Full Text] [Related]  

  • 16. HMGB1 and HMGB2 proteins up-regulate cellular expression of human topoisomerase IIalpha.
    Stros M; Polanská E; Struncová S; Pospísilová S
    Nucleic Acids Res; 2009 Apr; 37(7):2070-86. PubMed ID: 19223331
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Interference with topoisomerase IIalpha potentiates melphalan cytotoxicity.
    Hirota H; Gosky D; Berger NA; Chatterjee S
    Int J Oncol; 2002 Feb; 20(2):311-8. PubMed ID: 11788894
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Nuclear factor-Y binding to the topoisomerase IIalpha promoter is inhibited by both the p53 tumor suppressor and anticancer drugs.
    Joshi AA; Wu Z; Reed RF; Suttle DP
    Mol Pharmacol; 2003 Feb; 63(2):359-67. PubMed ID: 12527807
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Topoisomerase IIα prevents ultrafine anaphase bridges by two mechanisms.
    Gemble S; Buhagiar-Labarchède G; Onclercq-Delic R; Fontaine G; Lambert S; Amor-Guéret M
    Open Biol; 2020 May; 10(5):190259. PubMed ID: 32400307
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Topoisomerase II beta levels are a determinant of melphalan-induced DNA crosslinks and sensitivity to cell death.
    Emmons M; Boulware D; Sullivan DM; Hazlehurst LA
    Biochem Pharmacol; 2006 Jun; 72(1):11-8. PubMed ID: 16678798
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.